Patents by Inventor Meenakshi S. Venkatraman

Meenakshi S. Venkatraman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME
    Publication number: 20200407336
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Application
    Filed: July 13, 2020
    Publication date: December 31, 2020
    Applicant: CORSAIR PHARMA, INC.
    Inventors: Cyrus K. BECKER, Meenakshi S. VENKATRAMAN, Xiaoming ZHANG
  • AMINOADAMANTYL NITRATE COMPOUNDS AND THEIR USE TO TREAT CNS DISORDERS
    Publication number: 20200377444
    Abstract: The present disclosure provides adamantyl compounds having one or more amine groups and one or more nitrate groups. The aminoadamantyl nitrate compounds can be used to treat disorders of the central nervous system, including neurodegenerative and non-neurodegenerative diseases.
    Type: Application
    Filed: November 20, 2018
    Publication date: December 3, 2020
    Inventors: Cyrus K. BECKER, Meenakshi S. VENKATRAMAN, Xiaoming ZHANG, James W. LARRICK
  • Dry powder inhaler compositions of 7-azoniabicyclo[2.2.1]heptane derivatives
    Patent number: 10835514
    Abstract: Pharmaceutical compositions of muscarinic acetylcholine receptor antagonists suitable for administration via a dry powdered inhaler and methods of using the compositions for treating respiratory disease are provided.
    Type: Grant
    Filed: January 7, 2017
    Date of Patent: November 17, 2020
    Assignee: THERON PHARMACEUTICALS, INC.
    Inventors: Meenakshi S. Venkatraman, Xiaoming Zhang, Phillip Haywood
  • TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
    Publication number: 20200347006
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: May 21, 2020
    Publication date: November 5, 2020
    Applicant: CORSAIR PHARMA, INC.
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER
  • Treprostinil derivatives and compositions and uses thereof
    Patent number: 10759733
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Grant
    Filed: September 24, 2019
    Date of Patent: September 1, 2020
    Assignee: Corsair Pharma, Inc.
    Inventors: Xiaoming Zhang, Meenakshi S. Venkatraman, Cyrus K. Becker
  • Treprostinil derivative compounds and methods of using same
    Patent number: 10752605
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Grant
    Filed: May 21, 2019
    Date of Patent: August 25, 2020
    Assignee: Corsair Pharma, Inc.
    Inventors: Cyrus K. Becker, Meenakshi S. Venkatraman, Xiaoming Zhang
  • Treprostinil derivatives and compositions and uses thereof
    Patent number: 10703706
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: July 7, 2020
    Assignee: Corsair Pharma, Inc.
    Inventors: Xiaoming Zhang, Meenakshi S. Venkatraman, Cyrus K. Becker
  • TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
    Publication number: 20200095186
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: September 24, 2019
    Publication date: March 26, 2020
    Applicant: CORSAIR PHARMA, INC.
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER
  • TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
    Publication number: 20200071257
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: September 18, 2019
    Publication date: March 5, 2020
    Applicant: CORSAIR PHARMA, INC.
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER
  • TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME
    Publication number: 20200062726
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Application
    Filed: September 13, 2019
    Publication date: February 27, 2020
    Applicant: CORSAIR PHARMA, INC.
    Inventors: Cyrus K. BECKER, Meenakshi S. VENKATRAMAN, Xiaoming ZHANG
  • Treprostinil derivatives and compositions and uses thereof
    Patent number: 10464877
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Grant
    Filed: March 21, 2018
    Date of Patent: November 5, 2019
    Assignee: Corsair Pharma, Inc.
    Inventors: Xiaoming Zhang, Meenakshi S. Venkatraman, Cyrus K. Becker
  • Treprostinil derivatives and compositions and uses thereof
    Patent number: 10464878
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Grant
    Filed: July 19, 2018
    Date of Patent: November 5, 2019
    Assignee: Corsair Pharma, Inc.
    Inventors: Xiaoming Zhang, Meenakshi S. Venkatraman, Cyrus K. Becker
  • Treprostinil derivative compounds and methods of using same
    Patent number: 10450290
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Grant
    Filed: November 13, 2017
    Date of Patent: October 22, 2019
    Assignee: Corsair Pharma, Inc.
    Inventors: Cyrus K. Becker, Meenakshi S. Venkatraman, Xiaoming Zhang
  • DRY POWDER INHALER COMPOSITIONS OF 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES
    Publication number: 20190298690
    Abstract: Pharmaceutical compositions of muscarinic acetylcholine receptor antagonists suitable for administration via a dry powdered inhaler and methods of using the compositions for treating respiratory disease are provided.
    Type: Application
    Filed: January 7, 2017
    Publication date: October 3, 2019
    Inventors: Meenakshi S. VENKATRAMAN, Xiaoming ZHANG, Phillip HAYWOOD
  • DERMAL AND TRANSDERMAL ADMINISTRATION OF TREPROSTINIL AND SALTS THEREOF
    Publication number: 20190290597
    Abstract: The present disclosure provides methods, compositions, devices and systems for dermal and transdermal administration of treprostinil or salts thereof, and optionally an additional therapeutic agent. Treprostinil and salts thereof can be dermally or transdermally administered to treat any medical conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: December 5, 2017
    Publication date: September 26, 2019
    Inventors: Xiaoming ZHANG, Cyrus K. BECKER, Meenakshi S. VENKATRAMAN
  • TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME
    Publication number: 20190292163
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Application
    Filed: May 21, 2019
    Publication date: September 26, 2019
    Inventors: Cyrus K. BECKER, Meenakshi S. VENKATRAMAN, Xiaoming ZHANG
  • TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
    Publication number: 20190241499
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: February 8, 2019
    Publication date: August 8, 2019
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER
  • Treprostinil derivative compounds and methods of using same
    Patent number: 10344012
    Abstract: Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: July 9, 2019
    Assignee: Corsair Pharma, Inc.
    Inventors: Cyrus K. Becker, Meenakshi S. Venkatraman, Xiaoming Zhang, Jürg Pfister
  • Treprostinil derivatives and compositions and uses thereof
    Patent number: 10246403
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Grant
    Filed: June 14, 2016
    Date of Patent: April 2, 2019
    Assignee: CORSAIR PHARMA, INC.
    Inventors: Xiaoming Zhang, Meenakshi S. Venkatraman, Cyrus K. Becker
  • TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF
    Publication number: 20190010112
    Abstract: The present disclosure provides treprostinil derivatives that can act as prodrugs of treprostinil. The treprostinil derivatives can be used to treat any conditions responsive to treatment with treprostinil, including pulmonary hypertension, such as pulmonary arterial hypertension.
    Type: Application
    Filed: July 19, 2018
    Publication date: January 10, 2019
    Inventors: Xiaoming ZHANG, Meenakshi S. VENKATRAMAN, Cyrus K. BECKER